(Clostridioides difficile) is bacteria that causes about 500,000 infections a year in the United States, according to the U.S ...

Clostridioides difficile (C. diff) is a bacterial infection that commonly affects people with ulcerative colitis (UC). It can worsen symptoms and cause complications. It can also trigger a ...

Antibiotic and antifungal drug resistance pose a major public health threat. Live Science is covering the spread of this ...

CDI = Clostridium difficile infection, UTI = Urinary tract infection, n = total sample size, N = weighted average annual population estimate, CI = confidence interval ...

Pfizer's vaccine for Clostridium difficile (C. US biotech Vedanta Biosciences has been awarded up to $76.9 million to develop VE303 for high-risk Clostridioides difficile (C. diff.) infection by ...

Thank you for taking time to provide your feedback to the editors. Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.

Goldman Sachs analyst maintains Buy rating on Pfizer with $33 price target. Discusses update on 2nd-gen C. diff vaccine in ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.